Clinical Trials Navicent Health



The Navicent Health Institutional Review board operates under the guidance of the Ethical Principles and Guidelines for the Protection of Human Subjects of Research. This report, commonly referred to as the Belmont Report, contains ethical principles regarding all research involving human subjects as identified by the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. All sites within Navicent Health are required to conform to ethical principles of the highest standard as may be determined by the Department of Health and Human Services (DHHS) or Office of Civil Rights (OCR).

The Navicent Health Institutional Review Board (IRB) is charged with the responsibility of reviewing, prior to its initiation, all research (whether funded or not) involving human participants. The IRB has the sole authority to approve, disapprove, monitor, and require modifications in all research activities that fall within its jurisdiction as specified by both the federal regulations and institutional policy.

Any research conducted at a Navicent Health entity must be reviewed and approved by the Navicent Health Institutional Review Board.